Abstract
Dystrobrevin-binding protein 1 (DTNBP1), a gene encoding dysbindin-1, has been identified as a susceptibility gene for schizophrenia. Functioning with partners in synapses or the cytoplasm, this gene regulates neurite outgrowth and neurotransmitter release. Loss of dysbindin-1 affects schizophrenia pathology. Dysbindin-1 is also found in the nucleus, however, the characteristics of dysbindin in the nucleus are not fully understood. Here, we found that dysbindin-1A is degraded in the nucleus via the ubiquitin-proteasome system and that amino acids 2-41 at the N-terminus are required for this process. By interacting with p65, dysbindin-1A promotes the transcriptional activity of NF-kappa B in the nucleus and positively regulates MMP-9 expression. Taken together, the data obtained in this study demonstrate that dysbindin-1A protein levels are highly regulated in the nucleus and that dysbindin-1A regulates transcription factor NF-kappa B activity to promote the expression of MMP-9 and TNF-α.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cell Nucleus / metabolism*
-
Dysbindin
-
Dystrophin-Associated Proteins / chemistry
-
Dystrophin-Associated Proteins / metabolism*
-
Gene Expression Regulation, Enzymologic
-
HEK293 Cells
-
Humans
-
Matrix Metalloproteinase 9 / genetics
-
NF-kappa B / genetics
-
NF-kappa B / metabolism*
-
Proteasome Endopeptidase Complex / metabolism
-
Proteolysis*
-
Schizophrenia / metabolism*
-
Transcription, Genetic
-
Tumor Necrosis Factor-alpha / genetics
-
Ubiquitin / metabolism
Substances
-
DTNBP1 protein, human
-
Dysbindin
-
Dystrophin-Associated Proteins
-
NF-kappa B
-
Tumor Necrosis Factor-alpha
-
Ubiquitin
-
Matrix Metalloproteinase 9
-
Proteasome Endopeptidase Complex
Grants and funding
The National High-tech Research and Development program of China 973-projects (2012CB947602,
http://www.most.gov.cn/), the National Natural Sciences Foundation of China (Nos. 31330030 and 81371393,
http://www.nsfc.gov.cn/) and Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases (BM2013003,
http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.